You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

TRIMETHOPRIM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Trimethoprim patents expire, and when can generic versions of Trimethoprim launch?

Trimethoprim is a drug marketed by Dr Reddys Labs Sa, Novel Labs Inc, Novitium Pharma, Sun Pharm Industries, Teva, Watson Labs, Bausch And Lomb, Epic Pharma Llc, and Sandoz. and is included in ten NDAs.

The generic ingredient in TRIMETHOPRIM is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.

Drug patent expirations by year for TRIMETHOPRIM
Drug Prices for TRIMETHOPRIM

See drug prices for TRIMETHOPRIM

Drug Sales Revenue Trends for TRIMETHOPRIM

See drug sales revenues for TRIMETHOPRIM

Recent Clinical Trials for TRIMETHOPRIM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityEarly Phase 1
The Cleveland ClinicPhase 4
Assistance Publique - Hôpitaux de ParisPhase 4

See all TRIMETHOPRIM clinical trials

US Patents and Regulatory Information for TRIMETHOPRIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Sa TRIMETHOPRIM trimethoprim TABLET;ORAL 018679-001 Jul 30, 1982 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs TRIMETHOPRIM trimethoprim TABLET;ORAL 070049-001 Jun 6, 1985 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sun Pharm Industries TRIMETHOPRIM trimethoprim TABLET;ORAL 070494-001 Jan 22, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bausch And Lomb TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064120-001 Feb 14, 1997 AT RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.